2012
DOI: 10.1590/s1984-82502012000200005
|View full text |Cite
|
Sign up to set email alerts
|

Development and evaluation of ofloxacin orally disintegrating tablets

Abstract: Bitter taste of ofloxacin, a broad spectrum bactericidal agent, is masked and orally disintegrating tablets were formulated. The bitter taste is masked by forming complex between drug and weak cation exchange resins, Tulsion 335 and Indion 204. Effect of pH and drug:resin ratio on the drug loading was studied. Maximum drug loading was observed at pH 6. Ratio of 1:2 of drug:resin masked almost complete bitterness of ofloxacin. Formation of complexes was confirmed by IR spectroscopy. Physical characterization of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…However, further increase in pH (pH 12.0) had reduced drug loading due to reduced selectivity coefficient of amine drug (TAP) towards resin 24 , 30 . While strong affinity of H + ions for binding to the –COO − group of resin compared to drug contributed to lower drug loading at lower pH 25 .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, further increase in pH (pH 12.0) had reduced drug loading due to reduced selectivity coefficient of amine drug (TAP) towards resin 24 , 30 . While strong affinity of H + ions for binding to the –COO − group of resin compared to drug contributed to lower drug loading at lower pH 25 .…”
Section: Resultsmentioning
confidence: 99%
“…Thus, the adsorption-desorption features of KyronT-134 and Tulsion335 can be utilized in development of DRCs of pharmaceutical importance. Further DRCs can be dispensed in a variety of dosage forms like powder, chewing gums, suspension, conventional tablets or capsules 25 28 . Extended release resinates can maintain steady plasma drug levels, reduce frequency of multiple dosing, allows dose adjustment according to patient need and enhance adherence of patients to therapy 18 , 20 .…”
Section: Introductionmentioning
confidence: 99%